SEC Form 3 · accession 0001209191-17-009790
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R Brownsell
Officer — EVP
Period of report
Feb 1, 2017
Accepted (ET)
Feb 10, 2017 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 135,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of restricted common stock granted pursuant to Issuer's 2012 Omnibus Incentive Plan, which vest on January 24, 2018.